Two Eye-Catching Stocks: Callaway Golf Co. (NYSE:ELY), GlycoMimetics, Inc. (NASDAQ:GLYC)

9

Callaway Golf Co. (NYSE:ELY)

Callaway Golf Co. (NYSE:ELY) represented a move of 2.45 percent or $-0.45 per share and closed its previous day trading session at $15.49. 756385 Shares were traded in the last trading session with an Average Volume of 931.74 Million Shares. The stock currently has a Market Capitalization of 1.5 Billion.

Callaway Golf is renowned for developing innovative products that help golfers hit longer and straighter shots from tee to green; controlled, higher-spinning shots around the green; and smooth, accurate putts. The long list of legendary Callaway products introduced across the past three decades is long, punctuated by the iconic Big Bertha driver and the Great Big Bertha driver, which Golf Digest named the greatest club of all time for its combination of innovation, performance and lasting impact on the golf equipment landscape. Huge number of tournaments, including numerous Major Championships, have been won by Tour pros playing Callaway equipment. Callaway Golf consists of four powerful brands – Callaway, Odyssey, Toulon Design and OGIO – that together offer golfers all over the world everything they need – clubs, balls, bags, apparel, footwear, bags, accessories – to play better and enjoy the game more.

The stock traded between $ 9.99 and $15.95 over 1-Year time period showing its price to sales ratio of 1.43. Callaway Golf Co. (NYSE:ELY) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $6.84 and 200-Day Simple Moving Average of $13.68. Its Price to Free Cash Flow is 19.11 and Price to Book of 2.21.

Analyst’s recommended the stock as 2.1 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Callaway Golf Co. (NYSE:ELY) reported its Actual EPS of $-0.15/share. The analysts offering Earnings Estimates for the company were believing that Callaway Golf Co. could bring EPS of $-0.17/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 11.8 Percent.


GlycoMimetics, Inc. (NASDAQ:GLYC)

In the last trading session, GlycoMimetics, Inc. (NASDAQ:GLYC) added its value by 2.8% closing at the price of $24.64. The stock currently has market capitalization of 835.05 Million, with average volume of 702.61 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently GlycoMimetics, Inc. (NASDAQ:GLYC) is showing beta of 2.83. This particular value of beta suggests that GlycoMimetics, Inc. (NASDAQ:GLYC) has historically moved 283% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for GlycoMimetics, Inc. (NASDAQ:GLYC) is at $-1.24.

The stock currently has RSI of 65.66. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.

GlycoMimetics, Inc. (NASDAQ:GLYC) topped its 52-week high price of $25.20 on 01/19/18 and 52-Week Low Price of $ 3.82 on 05/11/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.48% and monthly volatility of 8.27% respectively.